Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, the ERASur Study

Recruiting

Phase 3

Total Ablative TherapyTesting the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, the ERASur Study

Sponsor:

Alliance for Clinical Trials in Oncology

Code:

NCT05673148

Conditions

Metastatic Colorectal Adenocarcinoma

Stage IV Colorectal Cancer AJCC V8

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Stereotactic Ablative Radiotherapy

Resection

Microwave Ablation

Chemotherapy

Computed Tomography

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-04-19. This information was provided to ClinicalTrials.gov by Alliance for Clinical Trials in Oncology on 2025-01-13.